Targeting Nociceptin/Orphanin FQ receptor to rescue cognitive symptoms in a mouse neuroendocrine model of chronic stress

被引:2
|
作者
da Silva, Flora D'Oliveira [1 ]
Robert, Cathaline [1 ]
Lardant, Emma [2 ]
Pizzano, Carina [3 ]
Bruchas, Michael R. [3 ]
Guiard, Bruno P. [1 ]
Chauveau, Frederic [2 ]
Mouledous, Lionel [1 ]
机构
[1] Univ Toulouse, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS,UMR 5169, Toulouse, France
[2] IRBA Army Biomed Res Inst, Bretigny Sur Orge, France
[3] Univ Washington, Ctr Excellence Neurobiol Addict Pain & Emot NAPE, Dept Anesthesiol, Seattle, WA 98195 USA
关键词
MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; ORPHANIN-FQ; NOP RECEPTOR; MEMORY; HIPPOCAMPUS; NEURONS; GLUCOCORTICOIDS; INVOLVEMENT; DISORDERS;
D O I
10.1038/s41380-023-02363-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic stress causes cognitive deficits, such as impairments in episodic-like hippocampus-dependent memory. Stress regulates an opioid-related neuropeptide named Nociceptin/Orphanin FQ (N/OFQ), the ligand of the G protein-coupled receptor NOP. Since this peptide has deleterious effects on memory, we hypothesized that the N/OFQ system could be a mediator of the negative effects of stress on memory. Chronic stress was mimicked by chronic exposure to corticosterone (CORT). The NOP receptor was either acutely blocked using selective antagonists, or knocked-down specifically in the hippocampus using genetic tools. Long-term memory was assessed in the object recognition (OR) and object location (OL) paradigms. Acute injection of NOP antagonists before learning had a negative impact on memory in naive mice whereas it restored memory performances in the chronic stress model. This rescue was associated with a normalization of neuronal cell activity in the CA3 part of the hippocampus. Chronic CORT induced an upregulation of the N/OFQ precursor in the hippocampus. Knock-down of the NOP receptor in the CA3/Dentate Gyrus region prevented memory deficits in the CORT model. These data demonstrate that blocking the N/OFQ system can be beneficial for long-term memory in a neuroendocrine model of chronic stress. We therefore suggest that NOP antagonists could be useful for the treatment of memory deficits in stress-related disorders.
引用
收藏
页码:718 / 729
页数:12
相关论文
共 50 条
  • [41] Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
    Salat, Kinga
    Furgala, Anna
    Salat, Robert
    INFLAMMOPHARMACOLOGY, 2018, 26 (02) : 361 - 374
  • [42] Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
    Kinga Sałat
    Anna Furgała
    Robert Sałat
    Inflammopharmacology, 2018, 26 : 361 - 374
  • [43] The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury
    Al Yacoub, Omar N.
    Tarantini, Stefano
    Zhang, Yong
    Csiszar, Anna
    Standifer, Kelly M.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [44] Regulation of the expression of nociceptin/orphanin fq, the opioid receptor-like 1 receptor (NOP), and inducible nos (iNOS) in a mouse microglial cell line, EOC20.
    Iver, V
    Brown, JM
    Gouty, S
    Rosenberger, J
    Cox, BM
    FASEB JOURNAL, 2006, 20 (05): : A1133 - A1133
  • [45] Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: Pharmacological and genetic evidence in the mouse forced swimming test
    Gavioli, EC
    Marzola, G
    Bertorelli, R
    Zucchini, S
    De Lima, TC
    Rae, GA
    Guerrini, R
    Salvadori, S
    Regoli, D
    Calo', G
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U13 - U13
  • [46] Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test
    Gavioli, EC
    Marzola, G
    Guerrini, R
    Bertorelli, R
    Zucchini, S
    De Lima, TCM
    Rae, GA
    Salvadori, S
    Regoli, D
    Calo, G
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (09) : 1987 - 1990
  • [47] Neurophysiological evidence of nociceptin/orphanin FQ (N/OFQ)/NOP receptor system involvement in patients with lower urinary tract symptoms (LUTS). Assessment of nociceptive flexion (RILL) reflex (NFR)
    Malagutti, S.
    Spinelli, M.
    Citeri, M.
    Lazzeri, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 167 - 167
  • [48] Neurophysiological evidence of Nociceptin/Orphanin FQ (N/OFQ)/NOP receptor system involvement in patients with lower urinary tract symptoms (LUTS). Assessment of nociceptive flexion (RIII) reflex (NFR)
    Lazzeri, Massimo
    Turini, Damiano
    Malagutti, Silvia
    Citeri, Marco
    Spinelli, Michele
    JOURNAL OF UROLOGY, 2007, 177 (04): : 329 - 330
  • [49] The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease
    Visanji, Naomi P.
    de Bie, Rob M. A.
    Johnston, Tom H.
    McCreary, Andrew C.
    Brotchie, Jonathan M.
    Fox, Susan H.
    MOVEMENT DISORDERS, 2008, 23 (13) : 1922 - 1925
  • [50] Nociceptin/orphanin FQ opioid peptide (NOP) receptor and μ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain
    Schiene, Klaus
    Schroeder, Wolfgang
    Linz, Klaus
    Frosch, Stefanie
    Tzschentke, Thomas M.
    Jansen, Ulla
    Christoph, Thomas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 832 : 90 - 95